Authors:
OREILLY LA
CULLEN L
MORIISHI K
OCONNOR L
HUANG DCS
STRASSER A
Citation: La. Oreilly et al., RAPID HYBRIDOMA SCREENING METHOD FOR THE IDENTIFICATION OF MONOCLONAL-ANTIBODIES TO LOW-ABUNDANCE CYTOPLASMIC PROTEINS, BioTechniques, 25(5), 1998, pp. 824
Authors:
GRUMONT RJ
ROURKE IJ
OREILLY LA
STRASSER A
MIYAKE K
SHA W
GERONDAKIS S
Citation: Rj. Grumont et al., B-LYMPHOCYTES DIFFERENTIALLY USE THE REL AND NUCLEAR FACTOR KAPPA-B1 (NF-KAPPA-B1) TRANSCRIPTION FACTORS TO REGULATE CELL-CYCLE PROGRESSIONAND APOPTOSIS IN QUIESCENT AND MITOGEN-ACTIVATED CELLS, The Journal of experimental medicine, 187(5), 1998, pp. 663-674
Citation: La. Oreilly et al., BCL-2 TRANSGENE EXPRESSION PROMOTES SURVIVAL AND REDUCES PROLIFERATION OF CD3-CD4-CD8-T CELL PROGENITORS, International immunology, 9(9), 1997, pp. 1291-1301
Citation: Dcs. Huang et al., THE ANTI-APOPTOSIS FUNCTION OF BCL-2 CAN BE GENETICALLY SEPARATED FROM ITS INHIBITORY EFFECT ON CELL-CYCLE ENTRY, EMBO journal, 16(15), 1997, pp. 4628-4638
Authors:
MARASKOVSKY E
OREILLY LA
TEEPE M
CORCORAN LM
PESCHON JJ
STRASSER A
Citation: E. Maraskovsky et al., BCL-2 CAN RESCUE T-LYMPHOCYTE DEVELOPMENT IN INTERLEUKIN-7 RECEPTOR-DEFICIENT MICE BUT NOT IN MUTANT RAG-1(- -) MICE/, Cell, 89(7), 1997, pp. 1011-1019
Authors:
OREILLY LA
HARRIS AW
TARLINTON DM
CORCORAN LM
STRASSER A
Citation: La. Oreilly et al., EXPRESSION OF A BCL-2 TRANSGENE REDUCES PROLIFERATION AND SLOWS TURNOVER OF DEVELOPING B-LYMPHOCYTES IN-VIVO, The Journal of immunology, 159(5), 1997, pp. 2301-2311
Citation: La. Oreilly et al., THE CELL-DEATH INHIBITOR BCL-2 AND ITS HOMOLOGS INFLUENCE CONTROL OF CELL-CYCLE ENTRY, EMBO journal, 15(24), 1996, pp. 6979-6990
Authors:
OREILLY LA
HEALEY D
SIMPSON E
CHANDLER P
LUND T
RITTER MA
COOKE A
Citation: La. Oreilly et al., STUDIES ON THE THYMUS OF NONOBESE DIABETIC (NOD) MICE - EFFECT OF TRANSGENE EXPRESSION, Immunology, 82(2), 1994, pp. 275-286